These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23557144)

  • 21. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair.
    Lu H; Huang D; Ransohoff RM; Zhou L
    FASEB J; 2011 Oct; 25(10):3344-55. PubMed ID: 21697550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid.
    Goto N; Akama K
    Microbiol Immunol; 1982; 26(12):1121-32. PubMed ID: 7169970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells.
    McKee AS; Burchill MA; Munks MW; Jin L; Kappler JW; Friedman RS; Jacobelli J; Marrack P
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):E1122-31. PubMed ID: 23447566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen.
    Reimer JM; Karlsson KH; Lövgren-Bengtsson K; Magnusson SE; Fuentes A; Stertman L
    PLoS One; 2012; 7(7):e41451. PubMed ID: 22844480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.
    Sagar D; Lamontagne A; Foss CA; Khan ZK; Pomper MG; Jain P
    J Neuroinflammation; 2012 Oct; 9():245. PubMed ID: 23102113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable Cationic Polycarbonates as Vaccine Adjuvants.
    Lee ALZ; Yang C; Gao S; Wang Y; Hedrick JL; Yang YY
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52285-52297. PubMed ID: 33179910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Critical analysis of reference studies on aluminium-based adjuvants toxicokinetics].
    Masson JD; Crépeaux G; Authier FJ; Exley C; Gherardi RK
    Ann Pharm Fr; 2017 Jul; 75(4):245-256. PubMed ID: 28576261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
    Kool M; Soullié T; van Nimwegen M; Willart MA; Muskens F; Jung S; Hoogsteden HC; Hammad H; Lambrecht BN
    J Exp Med; 2008 Apr; 205(4):869-82. PubMed ID: 18362170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
    Mohsen MO; Heath MD; Cabral-Miranda G; Lipp C; Zeltins A; Sande M; Stein JV; Riether C; Roesti E; Zha L; Engeroff P; El-Turabi A; Kundig TM; Vogel M; Skinner MA; Speiser DE; Knuth A; Kramer MF; Bachmann MF
    J Immunother Cancer; 2019 Apr; 7(1):114. PubMed ID: 31027511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization.
    Maa YF; Shu C; Ameri M; Zuleger C; Che J; Osorio JE; Payne LG; Chen D
    Pharm Res; 2003 Jul; 20(7):969-77. PubMed ID: 12880281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine.
    Hu Y; Smith D; Zhao Z; Harmon T; Pentel PR; Ehrich M; Zhang C
    Nanomedicine; 2019 Aug; 20():102023. PubMed ID: 31181264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.
    Magnusson SE; Reimer JM; Karlsson KH; Lilja L; Bengtsson KL; Stertman L
    Vaccine; 2013 Mar; 31(13):1725-33. PubMed ID: 23384754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice.
    Wang XY; Yao X; Wan YM; Wang B; Xu JQ; Wen YM
    Immunol Lett; 2013 Jan; 149(1-2):88-92. PubMed ID: 23183095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines.
    Tegenge MA; Von Tungeln LS; Anderson SA; Mitkus RJ; Vanlandingham MM; Forshee RA; Beland FA
    Regul Toxicol Pharmacol; 2019 Nov; 108():104436. PubMed ID: 31381939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses.
    Oleszycka E; McCluskey S; Sharp FA; Muñoz-Wolf N; Hams E; Gorman AL; Fallon PG; Lavelle EC
    Eur J Immunol; 2018 Apr; 48(4):705-715. PubMed ID: 29349774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Autoclaving on the Physicochemical Properties and Biological Activity of Aluminum Oxyhydroxide Used as an Adjuvant in Vaccines.
    Skiba M; Fatmi S; Milon N; Bounoure F; Lahiani-Skiba M
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.
    Seubert A; Monaci E; Pizza M; O'Hagan DT; Wack A
    J Immunol; 2008 Apr; 180(8):5402-12. PubMed ID: 18390722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and biodistribution of squalene-containing emulsion adjuvant following intramuscular injection of H5N1 influenza vaccine in mice.
    Tegenge MA; Von Tungeln LS; Mitkus RJ; Anderson SA; Vanlandingham MM; Forshee RA; Beland FA
    Regul Toxicol Pharmacol; 2016 Nov; 81():113-119. PubMed ID: 27498239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization.
    Ebensen T; Delandre S; Prochnow B; Guzmán CA; Schulze K
    Front Cell Infect Microbiol; 2019; 9():31. PubMed ID: 30838180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.